Walder Wyss has advised Holcim on the acquisition of CPC AG. Holcim Ltd., through its subsidiary, has completed the acquisition of CPC AG, a Swiss-based company...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised TecMed on the deal, while Walder Wyss advised Ypsomed. TecMed is taking a step towards becoming a global diabetes care leader fully focused...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised 14Trees on this transaction. 14Trees completed an exclusive Series A-1 round backed by Amazon’s Climate Pledge Fund, alongside founding investor Holcim. The joint...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised International Football Management in this transaction. Wasserman, a global sports, music and entertainment company, has acquired International Football Management (IFM). IFM has been...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised IPI Partners on the deal, while White & Case advised Deutsche Bank and Natixis as mandated lead arrangers and original lenders. PI Partners,...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised medmix in this transaction. Advestra acted as legal counsel to Credit Suisse and UBS. After its spin-off from Sulzer AG (SUN), medmix...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised Sulzer in this transaction. Sulzer Ltd announced the intention to spin-off its Applicator Systems (APS) division through a 1:1 share split. The listing...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
You must be a Standard 1 Year member to access this content.
Paul Hastings advised J.P. Morgan and Barclays Bank PLC on the deal. Walder Wyss and DLA Piper advised MKS Instruments. MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”),...
You must be a Standard 1 Year member to access this content.
